| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
500 |
463 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
250 |
239 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
95 |
94 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
59 |
59 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
46 |
46 |
$1K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
89 |
89 |
$805.45 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
65 |
65 |
$667.55 |